Achondroplasia, hypochondroplasia and thanatophoric dysplasia: Clinically related skeletal dysplasias that are also related at the molecular level

International Journal of Oral and Maxillofacial Surgery

Volumn 27, Issue 6, 1998, Pages 451-455

  Cohen Jr , M Michael ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Cloverleaf skull; Cranial base; Craniosynostosis; Disproportionate short stature; Endochondral bone formation; Fibroblast growth factor receptor 3 (FGFR3); Midface deficiency; Nasal capsule

Indexed keywords

FGFR3 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 3; PROTEIN TYROSINE KINASE;

ACHONDROPLASIA; BONE DEVELOPMENT; CHONDRODYSPLASIA; CRANIOFACIAL MALFORMATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MUTATION; PATHOLOGY; REVIEW; THANATOPHORIC DWARFISM;

ACHONDROPLASIA; BONE DEVELOPMENT; CRANIOFACIAL ABNORMALITIES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MUTATION; OSTEOCHONDRODYSPLASIAS; PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECEPTORS, FIBROBLAST GROWTH FACTOR; THANATOPHORIC DYSPLASIA;

EID: 0032253399     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0901-5027(98)80036-2     Document Type: Article

References (28)

1. BELLUS GA, BAMSHAD MJ, PRZYLEPA K et al. Skeletal-skin-brain dysplasia (SADDAN): Phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3 (in press).
2. BELLUS GA, GAUDENZ K, ZACKAI EH, CLARKE LA, SZABO J, FRANCOMANO CA, MUENKE M. Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nat Genet 1996: 14: 174-6.
3. BELLUS GA, HEFFERON TW, ORTIZ DE LUNA RI, HECHT JT, HORTON WA, MACHADO M, KAITILA I, MCINTOSH I, FRANCOMANO CA. Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet 1995: 56: 368.
4. BELLUS GA, MCINTOSH I, SMITH EA, AYLSWORTH AS, KAITILA I, HORTON WA, GREENAW GA, HECHT JT, FRANCOMANO CA. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nature Genet 1995: 10: 357-9.
5. BONAVENTURE J, ROUSSEAU F. LEGEAI-MALLET L, LE MERRER M, MUNNICH A, MAROTEAUX P. Common mutations in the fibroblast growth factor receptor 3 (FGFR3) gene account for achondroplasia, hypochondroplasia and thanatophoric dwarfism. Am J Med Genet 1996: 63: 148-54.
6. COHEN MM JR. FGFR3 associated coronal synostosis syndrome (Muenke craniosynostosis). In Craniosynostosis: Diagnosis, Evaluation, and Management, MM Cohen, Jr. and RE MacLean, Eds., Second Edition, Oxford University Press, New York, 1999, Chapter 23.
7. COHEN MM JR. Short-limb skeletal dysplasias and craniosynostosis: What do they have in common? Pediatr Radiol 1997: 27: 442-6.
8. COHEN MM JR. Thanatophoric dysplasia. In Craniosynostosis: Diagnosis, Evaluation, and Management, M.M. Cohen, Jr. and R.E. MacLean, Eds., Oxford University Press, New York, 1999, Chapter 27.
9. COHEN MM JR. The Child With Multiple Birth Defects, 2nd Ed., Oxford University Press, New York, 1997.
10. DENG C, WYNSHAW-BORIS A, ZHOU F, Kuo A, LEDER P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 1996: 84: 911-21.
11. ELEJALDE BR, DE ELEJALDE MM. Thanatophoric dysplasia: Fetal manifestations and prenatal diagnosis. Am J Med Genet 1985: 22: 669-83.
12. HAMILTON WJ, BOYD JD, MOSSMAN HW. Human Embryology. Cambridge: Heffer & Sons, p. 402, 1959.
13. MEYERS GA, ORLOW SJ, MUNRO IR, PRZYLEPA KA, JABS EW. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet 1995: 11: 462-4.
14. MUENKE M, FRANCOMANO CA, COHEN MM JR, JABS EW. Fibroblast growth factor receptor-related skeletal disorders. In: Principles of Molecular Medicine, J.L. Jameson, Ed., Humana Press, Inc., Totowa, New Jersey, 1998, Chapter 114, pp. 1-10.
15. MUENKE M, GRIPP KW, MCDONALD-MCGINN DM, GAUDENZ K, WHITAKER LA, BARTLETT SP, MARKOWITZ RI, ROBIN NH, NWOKORO N, MULVIHILL JJ, LOSKEN W, MULLIKEN JB, GUTTMACHER AK, WILROY RS, CLARKE LA, HOLLWAY G, ADÉS LC, HAAN EA, MULLEY JC, COHEN MM JR, BELLUS GA, FRANCOMANO CA, MOLONEY DM, WALL SA, WILKIE AOM, ZACKAI EH. A unique point mutation in the fibroblast growth factor receptor 3 (FGFR3) gene defines a new craniosynostosis syndrome. Am J Hum Genet 1997: 60: 555-4.
16. NASKI MC, WANG Q, ZU J, ORNITZ DM. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nature Genet 1996: 13: 233-7.
17. NEILSON KM, FRIESEL R. Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane, and kinase domains. J Biol Chem 1996: 271: 25049-57.
18. PRINOS P, KILPATRICK MW, TSIPOURAS P. A novel G346E FGFR3 mutation in achondroplasia. Pediatr Res 1995: 37:(4) pt 2:151 A (abstract 894).
19. ROUSSEAU F, EL GHOUZI V, DELEZOIDE AL, LEGEAI-MALLET L, LE MERRER M, MUNNICH A, BONVENTURE J. Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type 1 (TD1). Hum Mol Genet 1996: 5: 509-12.
20. ROUSSEAU F, SAUGIER P, LE MERRER M, MUNNICH A, DELEZOIDE A-L, MAROTEAUX P, BONVENTURE J, NARCY F SANAK M. Stop codon FGFR3 mutations in thanatophoric dwarfism type 1. Nat Genet 1995: 10: 11-2.
21. SHIANG R, THOMPSON LM, ZHU Y-Z, CHURCH DM, FIELDER TJ, BOCIAN M, WINOKUR ST, WASMUTH JJ. Mutations m the transmembrane domain of FGFR 3 cause the most common genetic form of dwarfism, achondroplasia. Cell 1994: 78: 335-42.
22. SUPERTI-FURGA A, EICH G, BUCHER HU, WISSER J, GIEDON A. GITZELMANN R, STEINMANN B. A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia. Eur J Pediatr 1995: 154: 215.
23. SZABO JK, WILKIN DJ, CAMERON R, HENDERSON S, BELLUS G, KAITILA I, LOUGHLIN J, MUNNICH A. SYKES B, BONAVENTURE J, FRANCOMANO CA. The achondroplasia mutation occurs exclusively on the paternally derived fibroblast growth factor receptor 3 (FGFR3) allele. Am J Hum Genet 1997: 60 (Suppl): Abstract No 2040.
24. TAVORMINA PL, RIMOIN DL, COHN DH, ZHU Y-Z, SHIANG R, WASMUTH JJ. Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type 1. Hum Mol Genet 1995: 4: 2175-7.
25. TAVORMINA PL, SHIANG R, THOMPSON LM, ZHU Y-Z, WILKIN DJ, LACHMAN RS, WILCOX WR, RIMOIN DL, COHN DH, WASMUTH JJ. Thanatophoric dysplasia (types 1 and 2) caused by distinct mutations in fibroblast growth factor receptor 3. Nat Genet 1995: 9: 321-8.
26. WEBSTER MK, DONOGHUE DJ. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J 1996: 15: 520-7.
27. WEBSTER MK, DONOGHUE D. FGFR activation in skeletal disorders: Too much of a good thing. TIG 1997: 13: 178-82.
28. WILCOX WR, TAVORMINA PL, KRAKOW D et al. Molecular radiologic, and histopathologie correlations in thanatophoric dysplasia. Am J Med Genet 1998: 274-81.